Table 1 Genetic association of activating KIRs with their putative ligands and the outcome of HCV infection in 336 individuals exposed to HCV (216 chronically infected and 120 with resolved HCV infection).

Logistic regression was performed using SPSS v20.0 using the ENTER method. OR > 1 indicates protection against chronic HCV infection.

POR95% CI
KIR2DL3/L3:HLA-C1/C10.0052.681.34–5.37
KIR3DS1:HLA-BBw40.0322.161.07–4.37
KIR2DS2:HLA-C10.0332.061.06–4.02
KIR2DS30.0330.510.27–0.95
KIR2DS1:HLA-C10.1700.590.28–1.25
KIR2DS2:HLA-A*110.3940.640.23–1.78
KIR2DS1:HLA-C20.5090.740.31–1.80
KIR2DS2:HLA-C20.7271.130.58–2.18